Biofrontera

BFRINASDAQ
$1.05
-0.05-4.09%
At Close: -
$1.02
-0.03-3.32%
After Hours: Jul 12, 5:30 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$20.00
Lowest Price Target1
$7.00
Consensus Price Target1
$15.00

Biofrontera (NASDAQ:BFRI) Stock, Analyst Ratings, Price Targets, Forecasts

Biofrontera Inc has a consensus price target of $15 based on the ratings of 3 analysts. The high is $20 issued by Roth Capital on November 24, 2021. The low is $7 issued by Benchmark on March 9, 2023. The 3 most-recent analyst ratings were released by Benchmark on August 31, 2023, July 5, 2023, and May 15, 2023, respectively. With an average price target of $14.33 between Benchmark, there's an implied 1305.23% upside for Biofrontera Inc from these most-recent analyst ratings.

Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Benchmark
Benchmark
Roth Capital

1calculated from analyst ratings

Analyst Ratings for Biofrontera

Buy NowGet Alert
08/31/2023Buy Now1664.71%Benchmark
Bruce Jackson
→ $18ReiteratesBuy → BuyGet Alert
07/05/2023Buy Now1664.71%Benchmark
Bruce Jackson
$140 → $18MaintainsBuyGet Alert
05/15/2023Buy Now586.27%Benchmark
Bruce Jackson
→ $140ReiteratesBuy → BuyGet Alert
03/09/2023Buy Now586.27%Benchmark
Jackson Ader
→ $140Reiterates → BuyGet Alert
01/31/2023Buy Now586.27%Benchmark
Bruce Jackson
$220 → $140Reiterates → BuyGet Alert
12/15/2021Buy Now978.43%Benchmark
Bruce Jackson
Initiates → BuyGet Alert
11/24/2021Buy Now1860.78%Roth Capital
Jonathan Aschoff
Initiates → BuyGet Alert

FAQ

Q

What is the target price for Biofrontera (BFRI) stock?

A

The latest price target for Biofrontera (NASDAQ:BFRI) was reported by Benchmark on August 31, 2023. The analyst firm set a price target for $18.00 expecting BFRI to rise to within 12 months (a possible 1664.71% upside). 1 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Biofrontera (BFRI)?

A

The latest analyst rating for Biofrontera (NASDAQ:BFRI) was provided by Benchmark, and Biofrontera reiterated their buy rating.

Q

When was the last upgrade for Biofrontera (BFRI)?

A

There is no last upgrade for Biofrontera

Q

When was the last downgrade for Biofrontera (BFRI)?

A

There is no last downgrade for Biofrontera.

Q

When is the next analyst rating going to be posted or updated for Biofrontera (BFRI)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biofrontera, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biofrontera was filed on August 31, 2023 so you should expect the next rating to be made available sometime around August 31, 2024.

Q

Is the Analyst Rating Biofrontera (BFRI) correct?

A

While ratings are subjective and will change, the latest Biofrontera (BFRI) rating was a reiterated with a price target of $0.00 to $18.00. The current price Biofrontera (BFRI) is trading at is $1.02, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch